相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis
Li-Na Zhang et al.
FEBS JOURNAL (2021)
FRMD6 has tumor suppressor functions in prostate cancer
Jakob Haldrup et al.
ONCOGENE (2021)
Prospecting for Breast Cancer Blood Biomarkers: Death-Associated Protein Kinase 1 (DAPK1) as a Potential Candidate
Benjamin Arko-Boham et al.
DISEASE MARKERS (2020)
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer
Nora Feldker et al.
EMBO JOURNAL (2020)
CD133: beyond a cancer stem cell biomarker
Amir Barzegar Behrooz et al.
JOURNAL OF DRUG TARGETING (2019)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer
Yanqiu Tong et al.
CANCER CELL INTERNATIONAL (2019)
Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells
Su In Lee et al.
PROSTATE (2019)
Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells
Qin Zhang et al.
EBIOMEDICINE (2019)
Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells
Ga-Bin Park et al.
MARINE DRUGS (2019)
DAPK1 loss triggers tumor invasion in colorectal tumor cells
Sara Steinmann et al.
CELL DEATH & DISEASE (2019)
Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer
Wenzheng Yuan et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
Bede van Schaijik et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Acquisition of tumorigenic potential and therapeutic resistance in CD133+subpopulation of prostate cancer cells exhibiting stem-cell like characteristics
Rajnee Kanwal et al.
CANCER LETTERS (2018)
ZEB1-mediated vasculogenic mimicry formation associates with epithelial-mesenchymal transition and cancer stem cell phenotypes in prostate cancer
Hua Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Therapeutic approaches targeting cancer stem cells
Yunzhi Pan et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
Shan Wang et al.
MOLECULAR NEUROBIOLOGY (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway
Qiji Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
Karen Hanrahan et al.
MOLECULAR ONCOLOGY (2017)
WNT signalling in prostate cancer
Virginia Murillo-Garzon et al.
NATURE REVIEWS UROLOGY (2017)
The Surgical Management of Prostate Cancer
Elisabeth M. Sebesta et al.
SEMINARS IN ONCOLOGY (2017)
DAPK1 as an independent prognostic marker in liver cancer
Ling Li et al.
PEERJ (2017)
Cardiac mortality associated with ADT plus radiotherapy
Michel Bolla et al.
NATURE REVIEWS UROLOGY (2016)
Gemcitabine treatment promotes pancreatic cancer sternness through the Nox/ROS/NF-κB/STAT3 signaling cascade
Zhengle Zhang et al.
CANCER LETTERS (2016)
Death Associated Protein Kinase 1 (DAPK1): A Regulator of Apoptosis and Autophagy
Pratibha Singh et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2015)
Cancer stem cells, cancer cell plasticity and radiation therapy
Erina Vlashi et al.
SEMINARS IN CANCER BIOLOGY (2015)
Growth kinetics of CD133-positive prostate cancer cells
Edwin E. Reyes et al.
PROSTATE (2013)
Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance
Takenori Ogawa et al.
CELL CYCLE (2012)
Alterations in Promoter Methylation Status of Tumor Suppressor HIC1, SFRP2, and DAPK1 Genes in Prostate Carcinomas
Devran Kilinc et al.
DNA AND CELL BIOLOGY (2012)
DAP kinase activates a p19(ARF)/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
T Raveh et al.
NATURE CELL BIOLOGY (2001)
分享论文
